Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Novartis AG | Novan, Inc.

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Vivoryon Therapeutics N.V.

BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  BioSenic SA

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Ipsen SA

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Pharming Group N.V.

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

Glycated Albumin Assay Market Projected to Reach $360.92 million by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

Green Water Labs to Host Community Clean-Up Event in Celebration of Earth Day 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024
Related companies:  Astellas Pharma Inc.

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Day One Biopharmaceuticals, Inc.

Pennant Announces First Quarter 2024 Earnings Release and Call

Read more ››
By: GlobeNewswire - 23 Apr 2024

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Seer, Inc.

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  ClearPoint Neuro, Inc.

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Read more ››
By: GlobeNewswire - 23 Apr 2024

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Shuttle Pharmaceuticals

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  OpGen, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑